Global biopharmaceutical company focused on discovering, developing, manufacturing, and marketing vaccines and antibody products, particularly for infectious diseases
Global biopharmaceutical company focused on discovering, developing, manufacturing, and marketing vaccines and antibody products, particularly for infectious diseases. Its portfolio includes marketed vaccines for pediatric, travel and endemic, and respiratory use, as well as candidates targeting influenza, tuberculosis, malaria, and rabies. Crucell uses its proprietary PER.C6 human-cell technology for product development and manufacturing.